Tuesday 25th November 2008 |
Text too small? |
Profit may rise to NZ$10-NZ$12 million in the year ending March 31, from NZ$7.8 million last year, the company said in a statement. There are risks to achieving the target should economic activity weaken further, it said.
"The extent of the current economic downturn is unprecedented and it represents a material risk factor for all New Zealand businesses,' said chair Alison Paterson. Healthcare "is reasonably protected from economic conditions" though there may be a drop off in discretionary spending on private healthcare, she said.
The company's stock rose 1.1% to NZ$1.55 and is down only 8% in a year when the benchmark NZX 50 Index fell four times as much. Abano has acquired specialist health clinics in Australia and at home in New Zealand, where it retains long-term public healthcare contracts that will help 'insulate' the company against any downturn, the company said.
She also gave an update on the first-half results, saying all businesses "are making good progress on last year."
"Some planned acquisitions have taken longer than expected to settle; however, we have made good progress in other business areas and acquisitions," she said.
Sales probably rose to NZ$85-NZ$86 million in the six months ending Nov. 30, from NZ$59.6 million a year earlier. Net profit rose to NZ$4.0-$4.3 million, from NZ$3.8 million.
No comments yet
Abano mulls rebel shareholder request for meeting, affirms support for Janes
Hutson fails to respond to Abano buyout offer, takeover 'rife with insider elements'
Abano steps up pressure on bidders over audiology unit price
Abano shareholders clamour for discounted stock in share purchase plan
Hutson quits Abano board after urging from other directors
Abano board questions Hutson's conflict of interest in takeover bid
Abano continues to resist takeovers, rejects approach from Archer, Hutson
Abano seeks $18.5 mln in share purchase plan
Abano shares climb to 4-month high amid prospect of takeover bid
Abano faces takeover bid after rejecting unsolicited offer